Purchase Order HT001424P0239

Award Date 9/30/24
Potential Completion Date 9/29/29
Potential Value $3.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of various kits and products related to biological agent identification, including assays and test kits for pathogens such as Yersinia pestis, Bacillus anthracis, and other agents. The total ceiling value of the contract is $149,706.00, and the ultimate completion date is May 3, 2017....
This is a firm fixed price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract has a ceiling value of $17,254.06 and an ultimate completion date of April 22, 2024. The contract provides medical supplies, with no set-aside designation. Biofire Defense has received prior federal contracts and grants, including a $6.2 million...
This is a firm fixed-price purchase order contract awarded by the Medical Supply Chain organization of the Defense Department to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract, valued at $6,614.55, is for the delivery of a FilmArray NGDS (Next Generation Diagnostic System) Warr (Warranty). The contract has no set-aside designation and has a completion date of November 7, 2024. Biofire Defense has previously...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Biofire Defense LLC, a for-profit limited liability company, for the delivery of 42 kits of the BioFire Global Fever Panel v2.1 IVD, 2 kits of the BioFire SHIELD Control Kit for the Global Fever Panel, and 3 kits of the Respiratory Panel 2.1 IVD. The total ceiling value of this contract is $90,259.00, with a period of performance ending on August 8, 2022. There was no set-aside...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for $632,736.78 to provide a respiratory panel for the Walter Reed National Military Medical Center, with a period of performance through May 25, 2024. The contract has no set-aside designation. Biofire Defense has previously received other federal contracts and grants...
This is a $472,500.00 firm fixed-price purchase order awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract provides an extended warranty for the company's TORCH MODULE product, with a period of performance through September 29, 2027. There is no set-aside designation for this award. Biofire Defense has previously received other federal contract and grant awards from the...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the Bureau of Administration to Biofire Defense LLC, a small business manufacturer of biological agent identification products and diagnostic solutions. The $3,866.83 contract is for the provision of Biofire lab test kits and products. Biofire Defense has been awarded several other federal contracts and grants, including a $6.2 million cooperative agreement from the Washington Headquarters Service to expand...
This is a fixed-price delivery order awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Biofire Defense LLC, a for-profit limited liability company. The $161,839.50 contract is for the provision of "KITS & SUPPORT CONSUMABLES" related to biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems, to support biodefense and infectious disease diagnostics. Biofire Defense has a history of providing a range of goods and...
This federal contract award with a ceiling value of $97,415.75 was issued by the Bureau of Medicine and Surgery (BUMED), a Defense agency, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of a FAIV KIT, RESPIRATORY PANEL, IVD 30 TEST and has a firm fixed price pricing type with a period of performance through September 28, 2018. There is no set-aside designation indicated for this award. In addition to this contract, Biofire Defense has received...
This is a firm-fixed price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for a lab order for health units with a total ceiling value of $12,691.53 and an ultimate completion date of January 21, 2024. Biofire Defense has previously received other federal prime contracts and subcontracts to provide a range of goods and...

This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biofire Defense LLC, a manufacturer of biological agent identification products. The contract is for the delivery of MOLECULAR DIAGNOSTICS KITS and has a ceiling value of $3,498,082.42 with a period of performance through September 29, 2029. There is no set-aside designation for this contract. Biofire Defense LLC has previously been awarded other prime and subcontract work with the Department of Defense, Department of State, National Institutes of Health, and other federal entities related to biological threat detection, infectious disease testing, and COVID-19 response efforts. This includes a $6.2 million cooperative agreement to expand manufacturing capacity for Department of Defense COVID test kits, as well as a $18.8 million indefinite delivery contract with the Army's Chemical and Biological Defense organization for sustainment of the Next Generation Diagnostic System.

Generated 12/31/24, 2:19 PM